Goldman Sachs
RNAZ icon

Goldman Sachs’s TransCode Therapeutics RNAZ Stock Holding History

Goldman Sachs’s Portfolio RNAZ Stock Details RNAZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$219K Buy
+28,042
New +$219K ﹤0.01% 4684
2023
Q2 		– Hold
0
– -$4.44K – 5107
2023
Q1 		– Hold
0
– -$11.5K – 5016
2022
Q4 		– Hold
0
– – – 4934